Research and Markets: Overview of Japanese OTC Market: Taisho Pharmaceuticals Dominates the Market Exceeding 130 billion JPY

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/qg7w5k/the_overview_of) has announced the addition of the "The Overview of Japanese OTC Market" report to their offering.

This report shows the overview of Japanese OTC market. The readers will understand overall market situation, including related regulations, market size, distribution channels, major OTC companies, along with current and future outlook.

Conventionally, OTC could only be purchased at pharmacies or drug stores in which a pharmacist was present, though as a result of the push for self-medication, deregulation has taken place progressively since 1999.

OTC is distributed either by wholesalers, or by the pharmaceutical manufacturers directly to retailers like pharmacies and drug stores. The ratio of wholesale to direct sales is about fifty-fifty. MHLW had determined in an ordinance that Type I and II OTC must be sold at a pharmacy or the like in a face-to-face transaction, banning internet sales in principle. At the time, internet sales accounted for approximately 2% of the overall market. Afterwards, the Supreme Court passed a ruling that MHLW's restrictions on internet sales were illegal in January 2013, and in June the cabinet of Prime Minister Abe brought up lifting the ban on internet sales as one of growth strategies. As a result, internet sales of OTC products were enabled under fixed conditions.

In contrast with prescription drugs, which have been on the rise year after year, OTC had been following a downward trend, while sales turned to increase in recent years. The biggest underlying factor lies in Japan's public health care system as cheaper and more effective prescription drugs can be taken by going to a clinic or hospital.

Taisho Pharmaceuticals is the leading company and features a wide-ranging line up in the field of OTC with exceeding 130 billion JPY as its revenue.

The engine of the future growth will be the expansion of internet sales. The official lifting of the ban on internet OTC sales will encourage participation by other industries. Also, OTC market growth depends on whether or not the government can bring forth systematic mechanisms to change the status quo of over dependence on prescription drugs.

Key Topics Covered:

  1. Summary
  2. Definition of Pharmaceuticals
  3. Definition of OTC
  4. Definition of Quasi-Drugs
  5. Type of OTC
  6. Switch OTC Products
  7. Related Laws and Regulations
  8. Deregulation History
  9. Distribution Channel
  10. Internet Sales
  11. Market Size
  12. Major Industrial Groups
  13. Overview of Top 5 OTC Companies
  14. Market Share by Type
  15. Breakdown by Medicinal Category
  16. General Market Outlook
  17. Future Outlook

Companies Mentioned

  • Daiichi Sankyo Healthcare
  • Rohto Pharmaceuticals
  • SS Pharmaceuticals
  • Taisho
  • Takeda

For more information visit http://www.researchandmarkets.com/research/qg7w5k/the_overview_of

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, OTC

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, OTC